유럽 부형제 시장, 원산지별(유기, 무기), 범주별(1차 부형제, 2차 부형제), 제품별(폴리머, 당, 알코올, 미네랄, 젤라틴, 기타), 화학 유형(식물, 동물, 합성, 미네랄), 화학 합성(락토오스 모노하이드레이트, 수크랄로스, 폴리소르베이트, 벤질 알코올, 세토스테아릴 아클로홀, 대두 레시틴, 프리젤라틴화 전분, 기타), 기능성(결합제 및 접착제, 붕해제, 코팅재, 붕해제, 용해제, 향미료, 감미제, 희석제, 윤활제, 완충제, 유화제, 방부제, 산화 방지제, 흡착제, 용매, 연화제, 활택제, 킬레이트제, 소포제, 기타), 투여 형태(고형, 반고형, 액체), 투여 경로(경구 부형제, 국소 부형제, 비경구 부형제, 기타 부형제), 최종 사용자(제약 및 생물제약 회사, 계약 제형사, 연구 기관 및 학계, 기타), 유통 채널(직접 입찰, 소매 판매, 기타), 국가(독일, 영국, 프랑스, 이탈리아, 스페인, 러시아, 폴란드, 스위스, 네덜란드, 헝가리, 오스트리아, 노르웨이, 아일랜드, 터키, 리투아니아, 유럽의 나머지 지역) 산업 동향 및 2028년까지의 예측
시장 분석 및 통찰력 : 유럽 보조제 시장
보조제 시장은 2021년에서 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년에서 2028년까지의 예측 기간 동안 5.8%의 CAGR로 성장하고 있으며 2028년까지 2,379.08백만 달러에 도달할 것으로 예상한다고 분석합니다. 대체 전달 경로/복용량 형태에 대한 수요 증가와 다양한 치료 영역에서 제약 보조제에 대한 필요성 증가는 예측 기간 동안 보조제 시장 수요를 촉진한 주요 요인입니다.
제약 부형제는 활성 제약 성분을 제외한 약물의 모든 것을 포함합니다 . 이 분자는 약효가 없으며 궁극적으로 약물의 생리적 흡수를 향상시키는 데 사용됩니다. 부형제는 본질적으로 불활성이며 약물 분자가 환자에게 올바른 형태로 적용될 수 있도록 합니다.
다기능성 부형제의 기술적 발전은 예측 기간 동안 부형제 시장 성장을 위한 원동력으로 작용합니다. 약물 개발 프로세스의 장기간은 예측 기간 동안 부형제 시장을 방해할 것으로 예상됩니다. 시장 참여자의 전략적 이니셔티브는 부형제 시장 성장의 기회로 작용합니다. 보관 및 운송 시의 안전 고려 사항은 부형제 시장 성장에 대한 과제로 작용합니다.
The excipients market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the excipients market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Excipients Market Scope and Market Size
The excipients market is categorized into ten notable segments which are based on the origin, category, products, chemistry type, chemical synthesis, functionality, dosage forms, route of administration, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of origin, the excipients market is segmented into organic and inorganic. In 2021, organic origin holds the highest market share due to non-toxic characteristic of organic chemicals used as excipients.
- On the basis of category, the excipients market is segmented into primary excipients and secondary excipients. In 2021, primary excipients segment is dominating the market as the segment includes fillers, adhesives, lubricants and other crucial excipients.
- On the basis of products, the excipients market is segmented into polymers, sugars, alcohols, minerals, gelatin and others. In 2021, polymers segment is dominating the market because polymers are used as gelatin shells in the manufacturing of capsules.
- On the basis of chemistry type, the excipients market is segmented into plant, animals, synthetic and minerals. In 2021, plant segment is dominating the market due to less expensive, non-toxic nature, biodegradable in nature and do not show any adverse effects of side effect on the human beings.
- On the basis of chemical synthesis, the excipients market is segmented into lactose monohydrate, sucralose, polysorbate, benzyl alcohol, cetosteary aclohol, soy lecithin, pregelatinized starch and others. In 2021, lactose monohydrate segment is dominating the market due to its multiple properties.
- On the basis of functionality, the excipients market is segmented into binders and adhesives, disintegrants, coating material, disintegrants, solubilizers, flavors, sweetening agents, diluents, lubricants, buffers, emulsifying agents, preservatives, antioxidants, sorbents, solvents, emollients, glidients, chelating agents, antifoaming agents and others. In 2021, binders and adhesives segment is dominating the market due to its properties.
- 투여 형태를 기준으로 부형제 시장은 고체 , 반고체 및 액체로 세분화됩니다. 2021년에는 대부분의 부형제가 고체 투여 형태의 제조에 사용되기 때문에 고체 세그먼트가 시장을 지배하고 있습니다.
- 투여 경로에 따라 부형제 시장은 경구 부형제, 국소 부형제, 비경구 부형제 및 기타 부형제로 세분화됩니다. 2021년에는 경구 부형제 세그먼트가 시장을 지배하고 있는데, 1차 치료제를 포함한 대부분의 약물이 강력한 작용 시작을 가진 가장 높은 효과를 가진 경구 형태로 제공되기 때문입니다.
- 최종 사용자를 기준으로, 부형제 시장은 제약 및 생물 제약 회사, 계약 조제자, 연구 기관 및 학계 및 기타로 세분화됩니다. 2021년에는 제약 및 생물 제약 회사 세그먼트가 시장을 지배하는데, 대부분의 부형제가 제약 및 생물 제약 회사에서 사용되기 때문입니다. 이러한 회사는 고체, 반고체 및 액체와 같은 모든 투여 형태의 의약품 생산을 담당하기 때문입니다.
- 유통 채널을 기준으로, 보조제 시장은 직접 입찰, 소매 판매 및 기타로 세분화됩니다. 2021년에는 직접 입찰 세그먼트가 보조제 유통의 주요 공급원이기 때문에 시장을 지배하고 있습니다.
유럽 보조제 시장 국가 수준 분석
위에 언급된 국가, 원산지, 범주, 제품, 화학 유형, 화학 합성, 기능, 투여 형태, 투여 경로, 최종 사용자 및 유통 채널을 기반으로 유럽 부형제 시장을 분석하고 시장 규모 정보를 제공합니다.
유럽 부형제 시장 보고서에서 다루는 국가는 독일, 영국, 프랑스, 이탈리아, 스페인, 러시아, 폴란드, 스위스, 네덜란드, 헝가리, 오스트리아, 노르웨이, 아일랜드, 터키, 리투아니아와 기타 유럽 국가입니다.
독일은 생물제약 분야의 혁신, 희귀의약품에 대한 관심 증가, 다기능성 부형제의 기술 발전으로 인해 예측 기간 동안 상당한 CAGR을 기록하며 유럽 부형제 시장을 주도하고 있습니다.
보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 유럽 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
시장 참여자의 전략적 이니셔티브는 첨가제 시장에서 새로운 기회를 창출하고 있습니다.
보조제 시장은 또한 보조제 시장 성장을 위한 모든 국가에 대한 자세한 시장 분석, 보조제 발전의 영향, 보조제 시장에 대한 지원과 함께 규제 시나리오의 변화를 제공합니다. 이 데이터는 2011년부터 2019년까지의 과거 기간에 대해 제공됩니다.
경쟁 환경 및 보조제 시장 점유율 분석
보조제 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선입니다. 위에 제공된 데이터 포인트는 유럽 보조제 시장과 관련된 회사의 초점에만 관련이 있습니다.
유럽 부형제 시장 보고서에 포함된 주요 기업으로는 DOW, Roquette Frères, JRS Pharma, Evonik Industries AG, The Lubrizol Corporation(Berkshire Hathaway Inc.의 자회사), BASF SE, Ashland, Kerry Group PLC, Shin-Etsu Chemical Co., Ltd., Colorcon, Chemische Fabrik Budenheim, Peter Greven GmbH & Co. KG, ADM, Croda International Plc, BENEO, Avantor, Inc., Omya AG, DFE Pharma, Pfanstiehl, Inc., MEGGLE Group Wasserburg 등이 있습니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.
또한 전 세계 여러 회사에서 많은 제품 출시와 계약을 체결하면서 보조제 시장도 활성화되고 있습니다.
예를 들어,
- 2020년 9월, Roquette Frères는 미국에서 의약품 유통을 위해 Barentz와 파트너십을 맺었습니다. 두 회사 모두 유럽 시장에서 유통 채널을 만들고 있습니다. 이 파트너십은 회사의 제품 포트폴리오를 늘릴 것입니다.
파트너십, 신제품 개발 및 기타 전략은 적용 범위와 존재감을 확대하여 회사 시장 점유율을 높입니다. 또한 조직이 확장된 규모 범위를 통해 보조제에 대한 제공을 개선할 수 있는 이점도 제공합니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE EXCIPIENTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 ORIGIN LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 EUROPE EXCIPIENTS MARKET: COUNTRIES WITH DATA OF IMPORTS AND EXPORTS
4.2 EUROPE EXCIPIETNS MARKET: COLOMBIA DATA OF THE ORIGIN COUNTRY OF THE IMPORTS
4.3 EUROPE EXCIPIENTS MARKET: COLOMBIA DATA OF THE IMPORTS AND EXPORTS BY MOLECULES IN VALUES AND VOLUMES
5 EUROPE EXCIPIENTS MARKET: REGULATORY SCENARIO
5.1 THE CANADA REGULATORY GUIDANCE FOR NON CLINICAL SAFETY EVALUATION OF PHARMACEUTICAL EXCIPIENTS
5.2 JAPAN REGULATORY FRAMEWORK FOR EXCIPIENTS
5.3 MIDDLE EAST AND AFRICA REGULATORY FRAMEWORK FOR EXCIPIENTS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 TECHNOLOGICAL ADVANCEMENTS IN MULTIFUNCTIONAL EXCIPIENTS
6.1.2 INCREASING NEED FOR PHARMACEUTICAL PRODUCTS ACROSS VARIED THERAPEUTIC AREAS
6.1.3 INNOVATIONS IN BIOPHARMACEUTICALS
6.1.4 INCREASING DEMAND & AVAILABILITY OF GENERIC DRUGS
6.1.5 RISING FOCUS ON ORPHAN DRUGS
6.2 RESTRAINTS
6.2.1 STRINGENT REGULATIONS
6.2.2 LONG DURATION OF DRUG DEVELOPMENT PROCESS
6.2.3 HIGH COST OF EXPERIMENTAL STUDIES OF EXCIPIENTS
6.3 OPPORTUNITIES
6.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.3.2 RISING DEMAND FOR EASE OF USE
6.3.3 RISING DISPOSABLE INCOME
6.3.4 INCREASING DEMAND FOR ALTERNATIVE ROUTES OF DELIVERY/DOSAGE FORMS
6.3.5 ASSOCIATED SIDE EFFECTS
6.3.6 SAFETY CONSIDERATION IN STORAGE & TRANSPORTATION
6.3.7 LACK OF NOVEL PHARMACEUTICAL EXCIPIENTS
7 IMPACT OF COVID-19 ON EUROPE EXCIPIENTS MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 MPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISION BY MANUFACTURERS
7.5 KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19
7.6 CONCLUSION
8 EUROPE EXCIPIENTS MARKET, BY ORIGIN
8.1 OVERVIEW
8.2 ORGANIC
8.3 INORGANIC
9 EUROPE EXCIPIENTS MARKET, BY CATEGORY
9.1 OVERVIEW
9.2 PRIMARY EXCIPIENTS
9.3 SECONDARY EXCIPIENTS
10 EUROPE EXCIPIENTS MARKET, BY PRODUCTS
10.1 OVERVIEW
10.2 POLYMERS
10.2.1 MCC
10.2.2 HPMC
10.2.3 ETHYL CELLULOSE
10.2.4 METHYL CELLULOSE
10.2.5 CMC
10.2.6 CROSCARMELLOSE SODIUM
10.2.7 POVIDONE
10.2.8 PREGELATINIZED STARCH
10.2.9 SODIUM STARCH GLYCOL
10.2.10 POLYETHYLENE GLYCOL
10.2.11 ACRYLIC POLYMERS
10.3 SUGAR
10.3.1 LACTOSE
10.3.2 SUCROSE
10.3.3 OTHERS
10.4 ALCOHOL
10.4.1 PROPYLENE GLYCOL
10.4.2 SORBITOL
10.4.3 MANNITOL
10.4.4 GLYCERIN
10.4.5 OTHERS
10.5 MINERALS
10.5.1 CALCIUM PHOSPHATE
10.5.2 CALCIUM CARBONATE
10.5.3 CLAY
10.5.4 SILICON DIOXIDE
10.5.5 TITANIUM DIOXIDE
10.5.6 OTHERS
10.6 GELATIN
10.7 OTHERS
11 EUROPE EXCIPIENTS MARKET, BY CHEMISTRY TYPE
11.1 OVERVIEW
11.2 PLANT
11.3 ANIMALS
11.4 SYNTHETIC
11.5 MINERALS
12 EUROPE EXCIPIENTS MARKET, BY CHEMISTRY SYNTHESIS
12.1 OVERVIEW
12.2 LACTOSE MONOHYDRATE
12.3 SUCRALOSE
12.4 POLYSORBATE
12.5 BENZYL ALCOHOL
12.6 CETOSTEARY ACLOHOL
12.7 SOY LECITHIN
12.8 PREGELATINIZED STARCH
12.9 OTHERS
13 EUROPE EXCIPIENTS MARKET, BY FUNCTIONALITY
13.1 OVERVIEW
13.2 BINDERS AND ADHESIVES
13.3 DISINTEGRANTS
13.4 COATING MATERIAL
13.5 COLORING AGENTS
13.6 SOLUBILIZERS
13.7 FLAVORS
13.8 SWEETENING AGENTS
13.9 DILUENTS
13.1 LUBRICANTS
13.11 BUFFERS
13.12 EMULSIFYING AGENTS
13.13 PRESERVATIVES
13.14 ANTIOXIDANTS
13.15 SORBENTS
13.16 SOLVENTS
13.17 EMOLLIENTS
13.18 GLIDIENTS
13.19 CHELATING AGENTS
13.2 ANTIFOAMING AGENTS
13.21 OTHERS
14 EUROPE EXCIPIENTS MARKET, BY DOSAGE FORM
14.1 OVERVIEW
14.2 SOLID
14.2.1 PLANT
14.2.2 ANIMALS
14.2.3 SYNTHETIC
14.2.4 MINERALS
14.3 SEMI-SOLID
14.3.1 PLANT
14.3.2 ANIMALS
14.3.3 SYNTHETIC
14.3.4 MINERALS
14.4 LIQUID
14.4.1 PLANT
14.4.2 ANIMALS
14.4.3 SYNTHETIC
14.4.4 MINERALS
15 EUROPE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION
15.1 OVERVIEW
15.2 ORAL EXCIPIENTS
15.3 TOPICAL EXCIPIENTS
15.4 PARENTERAL EXCIPIENTS
15.5 OTHER EXCIPIENTS
16 EUROPE EXCIPIENTS MARKET, BY END USER
16.1 OVERVIEW
16.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
16.3 CONTRACT FORMULATORS
16.4 RESEARCH ORGANIZATION AND ACADEMICS
16.5 OTHERS
17 EUROPE EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL
17.1 OVERVIEW
17.2 DIRECT TENDER
17.3 RETAIL SALES
17.4 OTHERS
18 EUROPE EXCIPIENTS MARKET, BY GEOGRAPHY
18.1 EUROPE
18.1.1 GERMANY
18.1.2 FRANCE
18.1.3 ITALY
18.1.4 SPAIN
18.1.5 U.K.
18.1.6 SWITZERLAND
18.1.7 IRELAND
18.1.8 NETHERLANDS
18.1.9 RUSSIA
18.1.10 HUNGARY
18.1.11 TURKEY
18.1.12 AUSTRIA
18.1.13 POLAND
18.1.14 NORWAY
18.1.15 LITHUANIA
18.1.16 REST OF EUROPE
19 EUROPE EXCIPIENTS MARKET: COMPANY LANDSCAPE
19.1 COMPANY SHARE ANALYSIS: EUROPE
20 SWOT ANALYSIS
21 COMPANY PROFILES
21.1 DOW
21.1.1 COMPANY SNAPSHOT
21.1.2 REVENUE ANALYSIS
21.1.3 COMPANY SHARE ANALYSIS
21.1.4 PRODUCT PORTFOLIO
21.1.5 RECENT DEVELOPMENTS
21.2 ROQUETTE FRÈRES
21.2.1 COMPANY SNAPSHOT
21.2.2 COMPANY SHARE ANALYSIS
21.2.3 PRODUCT PORTFOLIO
21.2.4 RECENT DEVELOPMENTS
21.3 JRS PHARMA
21.3.1 COMPANY SNAPSHOT
21.3.2 COMPANY SHARE ANALYSIS
21.3.3 PRODUCT PORTFOLIO
21.3.4 RECENT DEVELOPMENTS
21.4 EVONIK INDUSTRIES AG
21.4.1 COMPANY SNAPSHOT
21.4.2 REVENUE ANALYSIS
21.4.3 COMPANY SHARE ANALYSIS
21.4.4 PRODUCT PORTFOLIO
21.4.5 RECENT DEVELOPMENTS
21.5 THE LUBRIZOL CORPORATION (A SUBSIDIARY OF BERKSHIRE HATHAWAY INC.)
21.5.1 COMPANY SNAPSHOT
21.5.2 REVENUE ANALYSIS
21.5.3 COMPANY SHARE ANALYSIS
21.5.4 PRODUCT PORTFOLIO
21.5.5 RECENT DEVELOPMENT
21.6 BASF SE
21.6.1 COMPANY SNAPSHOT
21.6.2 REVENUE ANALYSIS
21.6.3 PRODUCT PORTFOLIO
21.6.4 RECENT DEVELOPMENTS
21.7 ASHLAND
21.7.1 COMPANY SNAPSHOT
21.7.2 REVENUE ANALYSIS
21.7.3 PRODUCT PORTFOLIO
21.7.4 RECENT DEVELOPMENTS
21.8 KERRY GROUP PLC
21.8.1 COMPANY SNAPSHOT
21.8.2 REVENUE ANALYSIS
21.8.3 PRODUCT PORTFOLIO
21.8.4 RECENT DEVELOPMENTS
21.9 SHIN-ETSU CHEMICAL CO., LTD.
21.9.1 COMPANY SNAPSHOT
21.9.2 REVENUE ANALYSIS
21.9.3 PRODUCT PORTFOLIO
21.9.4 RECENT DEVELOPMENTS
21.1 COLORCON
21.10.1 COMPANY SNAPSHOT
21.10.2 PRODUCT PORTFOLIO
21.10.3 RECENT DEVELOPMENTS
21.11 ADM
21.11.1 COMPANY SNAPSHOT
21.11.2 REVENUE ANALYSIS
21.11.3 PRODUCT PORTFOLIO
21.11.4 RECENT DEVELOPMENTS
21.12 AVANTOR, INC.
21.12.1 COMPANY SNAPSHOT
21.12.2 REVENUE ANALYSIS
21.12.3 PRODUCT PORTFOLIO
21.12.4 RECENT DEVELOPMENTS
21.13 BENEO
21.13.1 COMPANY SNAPSHOT
21.13.2 PRODUCT PORTFOLIO
21.13.3 RECENT DEVELOPMENTS
21.14 CHEMISCHE FABRIK BUDENHEIM
21.14.1 COMPANY SNAPSHOT
21.14.2 PRODUCT PORTFOLIO
21.14.3 RECENT DEVELOPMENTS
21.15 CRODA INTERNATIONAL PLC
21.15.1 COMPANY SNAPSHOT
21.15.2 REVENUE ANALYSIS
21.15.3 PRODUCT PORTFOLIO
21.15.4 RECENT DEVELOPMENTS
21.16 DFE PHARMA
21.16.1 COMPANY SNAPSHOT
21.16.2 PRODUCT PORTFOLIO
21.16.3 RECENT DEVELOPMENTS
21.17 MEGGLE GROUP WASSERBURG
21.17.1 COMPANY SNAPSHOT
21.17.2 PRODUCT PORTFOLIO
21.17.3 RECENT DEVELOPMENTS
21.18 OMYA AG
21.18.1 COMPANY SNAPSHOT
21.18.2 PRODUCT PORTFOLIO
21.18.3 RECENT DEVELOPMENTS
21.19 PETER GREVEN GMBH & CO. KG
21.19.1 COMPANY SNAPSHOT
21.19.2 PRODUCT PORTFOLIO
21.19.3 RECENT DEVELOPMENTS
21.2 PFANSTIEHL, INC.
21.20.1 COMPANY SNAPSHOT
21.20.2 PRODUCT PORTFOLIO
21.20.3 RECENT DEVELOPMENTS
22 QUESTIONNAIRE
23 RELATED REPORTS
표 목록
TABLE 1 EUROPE EXCIPIENTS MARKET, BY ORIGIN, 2017-2028 (USD MILLION)
TABLE 2 EUROPE ORGANIC IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 3 EUROPE INORGANIC IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 4 EUROPE EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 5 EUROPE PRIMARY EXCIPIENTS IN EXCIPIENT MARKETS, BY REGION, 2017-2028 (USD MILLION)
TABLE 6 EUROPE SECONDARY EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 7 EUROPE EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 8 EUROPE POLYMERS EXCIPIENTS IN EXCIPIENT MARKETS, BY REGION, 2017-2028 (USD MILLION)
TABLE 9 EUROPE POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 10 EUROPE SUGARS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 11 EUROPE SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 12 EUROPE ALCOHOLS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 13 EUROPE ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 14 EUROPE MINERALS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 15 EUROPE MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 16 EUROPE GELATIN IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 17 EUROPE OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 18 EUROPE EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 19 EUROPE PLANT IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 20 EUROPE ANIMALS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 21 EUROPE SYNTHETIC IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 22 EUROPE MINERALS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 23 EUROPE EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 24 EUROPE LACTOSE MONOHYDRATE IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 25 EUROPE SUCRALOSE IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 26 EUROPE POLYSORBATE IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 27 EUROPE BENZYL ALCOHOL IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 28 EUROPE CETOSTEARY ACLOHOL IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 29 EUROPE SOY LECITHIN IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 30 EUROPE PREGELATINIZED STARCH IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 31 EUROPE OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 32 EUROPE EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 33 EUROPE BINDERS AND ADHESIVES IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 34 EUROPE DISINTEGRANTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 35 EUROPE COATING MATERIAL IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 36 EUROPE COLORING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 37 EUROPE SOLUBILIZERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 38 EUROPE FLAVORS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 39 EUROPE SWEETENING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 40 EUROPE DILUENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 41 EUROPE LUBRICANTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 42 EUROPE BUFFERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 43 EUROPE EMULSIFYING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 44 EUROPE PRESERVATIVES IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 45 EUROPE ANTIOXIDANTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 46 EUROPE SORBENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 47 EUROPE SOLVENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 48 EUROPE EMOLLIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 49 EUROPE GLIDIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 50 EUROPE CHELATING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 51 EUROPE ANTIFOAMING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 52 EUROPE OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 53 EUROPE EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 54 EUROPE SOLID IN EXCIPIENT MARKETS, BY REGION, 2017-2028 (USD MILLION)
TABLE 55 EUROPE SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 56 EUROPE SEMI- SOLID IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 57 EUROPE SEMI- SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 58 EUROPE LIQUID IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 59 EUROPE LIQUID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 60 EUROPE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 61 EUROPE ORAL EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 62 EUROPE TOPICAL EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 63 EUROPE PARENTERAL EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 64 EUROPE OTHER EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 65 EUROPE EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 66 EUROPE PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 67 EUROPE CONTRACT FORMULATORS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 68 EUROPE RESEARCH ORGANIZATION AND ACADEMICS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 69 EUROPE OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 70 EUROPE EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2017-2028 (USD MILLION)
TABLE 71 EUROPE DIRECT TENDER IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 72 EUROPE RETAIL SALES IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 73 EUROPE OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)
TABLE 74 EUROPE EXCIPIENTS MARKET, BY COUNTRY, 2017-2028 (USD MILLION)
TABLE 75 EUROPE EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 76 EUROPE EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 77 EUROPE EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 78 EUROPE EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 79 EUROPE EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 80 EUROPE POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 81 EUROPE SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 82 EUROPE ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 83 EUROPE MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 84 EUROPE EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 85 EUROPE EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 86 EUROPE EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 87 EUROPE EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 88 EUROPE EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 89 EUROPE EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 90 EUROPE SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 91 EUROPE SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 92 EUROPE LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 93 EUROPE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 94 EUROPE EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 95 EUROPE EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 96 GERMANY EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 97 GERMANY EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 98 GERMANY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 99 GERMANY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 100 GERMANY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 101 GERMANY POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 102 GERMANY SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 103 GERMANY ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 104 GERMANY MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 105 GERMANY EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 106 GERMANY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 107 GERMANY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 108 GERMANY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 109 GERMANY EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 110 GERMANY EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 111 GERMANY SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 112 GERMANY SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 113 EUROPE LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 114 EUROPE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 115 GERMANY EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 116 GERMANY EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 117 FRANCE EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 118 FRANCE EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 119 FRANCE EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 120 FRANCE EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 121 FRANCE EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 122 FRANCE POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 123 FRANCE SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 124 FRANCE ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 125 FRANCE MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 126 FRANCE EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 127 FRANCE EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 128 FRANCE EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 129 FRANCE EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 130 FRANCE EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 131 FRANCE EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 132 FRANCE SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 133 FRANCE SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 134 FRANCE LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 135 FRANCE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 136 FRANCE EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 137 FRANCE EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 138 ITALY EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 139 ITALY EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 140 ITALY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 141 ITALY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 142 ITALY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 143 ITALY POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 144 ITALY SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 145 ITALY ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 146 ITALY MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 147 ITALY EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 148 ITALY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 149 ITALY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 150 ITALY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 151 ITALY EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 152 ITALY EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 153 ITALY SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 154 ITALY SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 155 ITALY LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 156 EUROPE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 157 ITALY EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 158 ITALY EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 159 SPAIN EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 160 SPAIN EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 161 SPAIN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 162 SPAIN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 163 SPAIN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 164 SPAIN POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 165 SPAIN SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 166 SPAIN ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 167 SPAIN MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 168 SPAIN EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 169 SPAIN EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 170 SPAIN EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 171 SPAIN EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 172 SPAIN EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 173 SPAIN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 174 SPAIN SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 175 SPAIN SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 176 SPAIN LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 177 SPAIN EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 178 SPAIN EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 179 SPAIN EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 180 U.K. EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 181 U.K. EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 182 U.K. EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 183 U.K. EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 184 U.K. EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 185 U.K. POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 186 U.K. SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 187 U.K. ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 188 U.K. MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 189 U.K. EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 190 U.K. EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 191 U.K. EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 192 U.K. EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 193 U.K. EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 194 U.K. EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 195 U.K. SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 196 U.K. SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 197 U.K. LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 198 U.K. EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 199 U.K. EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 200 U.K. EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 201 SWITZERLAND EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 202 SWITZERLAND EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 203 SWITZERLAND EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 204 SWITZERLAND EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 205 SWITZERLAND EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 206 SWITZERLAND POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 207 SWITZERLAND SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 208 SWITZERLAND ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 209 SWITZERLAND MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 210 SWITZERLAND EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 211 SWITZERLAND EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 212 SWITZERLAND EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 213 SWITZERLAND EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 214 SWITZERLAND EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 215 SWITZERLAND EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 216 SWITZERLAND SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 217 SWITZERLAND SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 218 SWITZERLAND LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 219 SWITZERLAND EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 220 SWITZERLAND EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 221 SWITZERLAND EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 222 IRELAND EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 223 IRELAND EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 224 IRELAND EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 225 IRELAND EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 226 IRELAND EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 227 IRELAND POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 228 IRELAND SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 229 IRELAND ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 230 IRELAND MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 231 IRELAND EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 232 IRELAND EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 233 IRELAND EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 234 IRELAND EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 235 IRELAND EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 236 IRELAND EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 237 IRELAND SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 238 IRELAND SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 239 IRELAND LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 240 IRELAND EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 241 IRELAND EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 242 IRELAND EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 243 NETHERLANDS EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 244 NETHERLANDS EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 245 NETHERLANDS EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 246 NETHERLANDS EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 247 NETHERLANDS EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 248 NETHERLANDS POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 249 NETHERLANDS SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 250 NETHERLANDS ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 251 NETHERLANDS MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 252 NETHERLANDS EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 253 NETHERLANDS EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 254 NETHERLANDS EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 255 NETHERLANDS EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 256 NETHERLANDS EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 257 NETHERLANDS EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 258 NETHERLANDS SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 259 NETHERLANDS SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 260 NETHERLANDS LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 261 NETHERLANDS EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 262 NETHERLANDS EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 263 NETHERLANDS EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 264 RUSSIA EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 265 RUSSIA EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 266 RUSSIA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 267 RUSSIA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 268 RUSSIA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 269 RUSSIA POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 270 RUSSIA SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 271 RUSSIA ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 272 RUSSIA MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 273 RUSSIA EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 274 RUSSIA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 275 RUSSIA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 276 RUSSIA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 277 RUSSIA EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 278 RUSSIA EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 279 RUSSIA SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 280 RUSSIA SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 281 RUSSIA LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 282 RUSSIA EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 283 RUSSIA EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 284 RUSSIA EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 285 HUNGARY EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 286 HUNGARY EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 287 HUNGARY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 288 HUNGARY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 289 HUNGARY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 290 HUNGARY POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 291 HUNGARY SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 292 HUNGARY ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 293 HUNGARY MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 294 HUNGARY EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 295 HUNGARY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 296 HUNGARY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 297 HUNGARY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 298 HUNGARY EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 299 HUNGARY EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 300 HUNGARY SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 301 HUNGARY SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 302 HUNGARY LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 303 HUNGARY EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 304 HUNGARY EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 305 HUNGARY EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 306 TURKEY EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 307 TURKEY EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 308 TURKEY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 309 TURKEY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 310 TURKEY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 311 TURKEY POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 312 TURKEY SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 313 TURKEY ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 314 TURKEY MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 315 TURKEY EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 316 TURKEY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 317 TURKEY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 318 TURKEY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 319 TURKEY EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 320 TURKEY EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 321 TURKEY SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 322 TURKEY SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 323 TURKEY LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 324 TURKEY EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 325 TURKEY EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 326 TURKEY EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 327 AUSTRIA EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 328 AUSTRIA EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 329 AUSTRIA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 330 AUSTRIA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 331 AUSTRIA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 332 AUSTRIA POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 333 AUSTRIA SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 334 AUSTRIA ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 335 AUSTRIA MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 336 AUSTRIA EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 337 AUSTRIA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 338 AUSTRIA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 339 AUSTRIA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 340 AUSTRIA EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 341 AUSTRIA EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 342 AUSTRIA SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 343 AUSTRIA SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 344 AUSTRIA LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 345 AUSTRIA EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 346 AUSTRIA EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 347 AUSTRIA EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 348 POLAND EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 349 POLAND EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 350 POLAND EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 351 POLAND EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 352 POLAND EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 353 POLAND POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 354 POLAND SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 355 POLAND ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 356 POLAND MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 357 POLAND EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 358 POLAND EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 359 POLAND EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 360 POLAND EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 361 POLAND EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 362 POLAND EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 363 POLAND SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 364 POLAND SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 365 POLAND LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 366 POLAND EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 367 POLAND EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 368 POLAND EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 369 NORWAY EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 370 NORWAY EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 371 NORWAY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 372 NORWAY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 373 NORWAY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 374 NORWAY POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 375 NORWAY SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 376 NORWAY ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 377 NORWAY MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 378 NORWAY EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 379 NORWAY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 380 NORWAY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 381 NORWAY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 382 NORWAY EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 383 NORWAY EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 384 NORWAY SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 385 NORWAY SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 386 NORWAY LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 387 NORWAY EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 388 NORWAY EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 389 NORWAY EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 390 LITHUANIA EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
TABLE 391 LITHUANIA EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)
TABLE 392 LITHUANIA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 393 LITHUANIA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)
TABLE 394 LITHUANIA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)
TABLE 395 LITHUANIA POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)
TABLE 396 LITHUANIA SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 397 LITHUANIA ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 398 LITHUANIA MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)
TABLE 399 LITHUANIA EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)
TABLE 400 LITHUANIA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)
TABLE 401 LITHUANIA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)
TABLE 402 LITHUANIA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)
TABLE 403 LITHUANIA EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)
TABLE 404 LITHUANIA EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 405 LITHUANIA SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 406 LITHUANIA SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 407 LITHUANIA LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)
TABLE 408 LITHUANIA EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)
TABLE 409 LITHUANIA EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)
TABLE 410 LITHUANIA EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)
TABLE 411 REST OF EUROPE EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)
그림 목록
FIGURE 1 EUROPE EXCIPIENTS MARKET: SEGMENTATION
FIGURE 2 EUROPE EXCIPIENTS MARKET : DATA TRIANGULATION
FIGURE 3 EUROPE EXCIPIENTS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE EXCIPIENTS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE EXCIPIENTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE EXCIPIENTS MARKET: MULTIVARIATE MODELLING
FIGURE 7 EUROPE EXCIPIENTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 EUROPE EXCIPIENTS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE EXCIPIENTS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 EUROPE EXCIPIENTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 EUROPE EXCIPIENTS MARKET: SEGMENTATION
FIGURE 12 TECHNOLOGICAL ADVANCEMENTS IN MULTIFUNCTIONAL EXCIPIENTS AND INNOVATION IN BIOPHARMACEUTICALS IS DRIVING THE EUROPE EXCIPIENTS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 ORGANIC SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE EXCIPIENTS MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE EUROPE EXCIPIENTS MARKET
FIGURE 15 APPROVAL OF GENERIC MEDICINES BY USFDA
FIGURE 16 EUROPE EXCIPIENTS MARKET: BY ORIGIN, 2020
FIGURE 17 EUROPE EXCIPIENTS MARKET: BY ORIGIN, 2020-2028 (USD MILLION)
FIGURE 18 EUROPE EXCIPIENTS MARKET: BY ORIGIN, CAGR (2020-2028)
FIGURE 19 EUROPE EXCIPIENTS MARKET: BY ORIGIN, LIFELINE CURVE
FIGURE 20 EUROPE EXCIPIENTS MARKET: BY CATEGORY, 2020
FIGURE 21 EUROPE EXCIPIENTS MARKET: BY CATEGORY, 2020-2028 (USD MILLION)
FIGURE 22 EUROPE EXCIPIENTS MARKET: BY CATEGORY, CAGR (2020-2028)
FIGURE 23 EUROPE EXCIPIENTS MARKET: BY CATEGORY, LIFELINE CURVE
FIGURE 24 EUROPE EXCIPIENTS MARKET: BY PRODUCTS, 2020
FIGURE 25 EUROPE EXCIPIENTS MARKET: BY PRODUCTS, 2020-2028 (USD MILLION)
FIGURE 26 EUROPE EXCIPIENTS MARKET: BY PRODUCTS, CAGR (2020-2028)
FIGURE 27 EUROPE EXCIPIENTS MARKET: BY PRODUCTS, LIFELINE CURVE
FIGURE 28 EUROPE EXCIPIENTS MARKET: BY CHEMISTRY TYPE, 2020
FIGURE 29 EUROPE EXCIPIENTS MARKET: BY CHEMISTRY TYPE, 2020-2028 (USD MILLION)
FIGURE 30 EUROPE EXCIPIENTS MARKET: BY CHEMISTRY TYPE, CAGR (2020-2028)
FIGURE 31 EUROPE EXCIPIENTS MARKET: BY CHEMISTRY TYPE, LIFELINE CURVE
FIGURE 32 EUROPE EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, 2020
FIGURE 33 EUROPE EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, 2020-2028 (USD MILLION)
FIGURE 34 EUROPE EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, CAGR (2020-2028)
FIGURE 35 EUROPE EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, LIFELINE CURVE
FIGURE 36 EUROPE EXCIPIENTS MARKET: BY FUNCTIONALITY, 2020
FIGURE 37 EUROPE EXCIPIENTS MARKET: BY FUNCTIONALITY, 2020-2028 (USD MILLION)
FIGURE 38 EUROPE EXCIPIENTS MARKET: BY FUNCTIONALITY, CAGR (2020-2028)
FIGURE 39 EUROPE EXCIPIENTS MARKET: BY FUNCTIONALITY, LIFELINE CURVE
FIGURE 40 EUROPE EXCIPIENTS MARKET: BY DOSAGE FORMS, 2020
FIGURE 41 EUROPE EXCIPIENTS MARKET: BY DOSAGE FORMS, 2020-2028 (USD MILLION)
FIGURE 42 EUROPE EXCIPIENTS MARKET: BY DOSAGE FORMS, CAGR (2020-2028)
FIGURE 43 EUROPE EXCIPIENTS MARKET: BY DOSAGE FORMS, LIFELINE CURVE
FIGURE 44 EUROPE EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, 2020
FIGURE 45 EUROPE EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, 2020-2028 (USD MILLION)
FIGURE 46 EUROPE EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2020-2028)
FIGURE 47 EUROPE EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 48 EUROPE EXCIPIENTS MARKET: BY END USER, 2020
FIGURE 49 EUROPE EXCIPIENTS MARKET: BY END USER, 2020-2028 (USD MILLION)
FIGURE 50 EUROPE EXCIPIENTS MARKET: BY END USER, CAGR (2020-2028)
FIGURE 51 EUROPE EXCIPIENTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 52 EUROPE EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 53 EUROPE EXCIPIENTS MARKET: BY DISTRIBUTION CHAN, 2020-2028 (USD MILLION)
FIGURE 54 EUROPE EXCIPIENTS MARKET: BY DISTRIBUTION CHAN, CAGR (2020-2028)
FIGURE 55 EUROPE EXCIPIENTS MARKET: BY DISTRIBUTION CHAN, LIFELINE CURVE
FIGURE 56 EUROPE EXCIPIENTS MARKET: SNAPSHOT (2020)
FIGURE 57 EUROPE EXCIPIENTS MARKET: BY COUNTRY (2020)
FIGURE 58 EUROPE EXCIPIENTS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 59 EUROPE EXCIPIENTS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 60 EUROPE EXCIPIENTS MARKET: BY ORIGIN (2021-2028)
FIGURE 61 EUROPE EXCIPIENTS MARKET: COMPANY SHARE 2020 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
